Email
Print
The
Exocrine Pancreatic Insufficiency Market deals with the development of therapies to provide EPI treatment. Exocrine Pancreatic Insufficiency (EPI) is a condition of inability to digest food properly, due to insufficient pancreatic enzymes. This condition is also called as Maldigestion.
Various kinds of diagnostic tests like blood tests, endoscopic ultra-sonography, magnetic resonance imaging, CT scanning and some others, are available in the market to detect EPI disease. Pancreatitis symptoms are Diarrhoea, Steatorrhea, fatigue and weight loss. EPI disturbs the normal growth, life expectancy and immune response. Increasing number of diseases like cystic fibrosis, chronic pancreatitis and diabetes is one of the key growth driver for the Exocrine Pancreatic Insufficiency Market.
Rising number of people suffering from diabetes and increasing demands for advanced therapies are the prime growth drivers of Exocrine Pancreatic Insufficiency Market. In addition, emergence of New Chemical Entities (NCEs) in various phases of clinical trials will create new opportunities for the market. Among all the tests, CT scanning is having the highest market share.
However, higher cost of EPI R & D and stringent government regulations or the approval of Pancreatic Enzyme Replacement Therapy (PERT) products are the key restraints for the Exocrine Pancreatic Insufficiency Market. But, presence of significant number of pipeline drugs encourages the market to drive the fast growth.
North America is dominating the Exocrine Pancreatic Insufficiency Market due to rapidly growing incidences of exocrine pancreatic insufficiency and other causative diseases like CF & CP in the US. It is also projected to have the fastest growth during the forecast period. Asia-Pacific is in the next position followed by Europe.
Various kinds of diagnostic tests like blood tests, endoscopic ultra-sonography, magnetic resonance imaging, CT scanning and some others, are available in the market to detect EPI disease. Pancreatitis symptoms are Diarrhoea, Steatorrhea, fatigue and weight loss. EPI disturbs the normal growth, life expectancy and immune response. Increasing number of diseases like cystic fibrosis, chronic pancreatitis and diabetes is one of the key growth driver for the Exocrine Pancreatic Insufficiency Market.
Rising number of people suffering from diabetes and increasing demands for advanced therapies are the prime growth drivers of Exocrine Pancreatic Insufficiency Market. In addition, emergence of New Chemical Entities (NCEs) in various phases of clinical trials will create new opportunities for the market. Among all the tests, CT scanning is having the highest market share.
However, higher cost of EPI R & D and stringent government regulations or the approval of Pancreatic Enzyme Replacement Therapy (PERT) products are the key restraints for the Exocrine Pancreatic Insufficiency Market. But, presence of significant number of pipeline drugs encourages the market to drive the fast growth.
North America is dominating the Exocrine Pancreatic Insufficiency Market due to rapidly growing incidences of exocrine pancreatic insufficiency and other causative diseases like CF & CP in the US. It is also projected to have the fastest growth during the forecast period. Asia-Pacific is in the next position followed by Europe.
Browse Related Reports:
- Lyme Disease Diagnostic Devices Market Analysis: By Diagnostic Tests (Serological, Lymphocytic Transformation, PCR Analysis, Immunofluorescence Staining); By Technologies (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry) - Forecast (2017 -2022)
https://www.industryarc.com/Report/7361/Lyme-Disease-Diagnostic-Devices-Market-Research-Report.html
- Allergy Diagnostics Market: By Allergy Type (Allergies: Food, Seasonal, Drug, Others) Diagnostic Test Type (In Vivo Test, In Vitro Test, Others) Product Type (Assays, Consumables, Others) End Users (Diagnostic & Research Institutes, Others)-Forecast(2017-2022)
https://www.industryarc.com/Report/10601/allergy-diagnostics-market.html
About IndustryARC:
IndustryARC
is a research and consulting firm that publishes more than 500 reports
annually in various industries, such as Agriculture, Automotive,
Automation & Instrumentation, Chemicals and Materials, Energy and
Power, Electronics, Food & Beverages, Information Technology, Life
sciences & Healthcare.
IndustryARC
primarily focuses on Cutting Edge Technologies and Newer Applications
of the Market. Our Custom Research Services are designed to provide
insights on the constant flux in the global demand-supply gap of
markets. Our strong analyst team enables us to meet the client research
needs at a very quick speed with a variety of options for your business.
We
look forward to support the client to be able to better address
customer needs; stay ahead in the market; become the top competitor and
get real-time recommendations on business strategies and deals. Contact
us to find out how we can help you today.
Contact Us:
Mr. Venkateshwar Reddy
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn - https://www.linkedin.com/company/industryarc